Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biofrontera Inc (NQ: BFRI )

3.570 +0.240 (+7.21%)
Streaming Delayed Price Updated: 3:58 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,310
Open 3.300
Bid (Size) 3.430 (1)
Ask (Size) 3.600 (25)
Prev. Close 3.330
Today's Range 3.220 - 3.600
52wk Range 2.730 - 22.39
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks – Biofrontera Inc. (NASDAQ: BFRI) Announces $4.5M Registered Direct
Via Investor Brand Network
Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update
Via ACCESSWIRE

Performance

YTD
-78.88%
-78.88%
1 Month
-13.98%
-13.98%
3 Month
-58.00%
-58.00%
6 Month
-60.00%
-60.00%
1 Year
-81.69%
-81.69%

More News

Read More
Biofrontera's Earnings Outlook
Via Benzinga
Biofrontera Inc. to Report Third Quarter 2023 Financial Results on November 9 and Hold Conference Call on November 10
Via ACCESSWIRE
Biofrontera Inc. Announces $4.5 Million Registered Direct Offering Priced At-the-market Under NASDAQ Rules
Via ACCESSWIRE
Biofrontera Inc. Receives FDA Approval for New Formulation of Ameluz(R)
Via ACCESSWIRE
Biofrontera Inc. Announces Preliminary Third Quarter Revenues
Via ACCESSWIRE
Biofrontera Inc. Reports Second Quarter 2023 Financial Results and Provides a Business Update
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Biofrontera Inc. to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference
Via ACCESSWIRE
Biofrontera Inc. Appoints Samantha Widdicombe to Support Commercial Relationships with Strategic Customer Accounts
Via ACCESSWIRE
Biofrontera Inc. Announces Positive Results from Phase 1 Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz(R)
Via ACCESSWIRE
Earnings Outlook For Biofrontera
Via Benzinga
Biofrontera Inc. Announces Last Patient Enrolled in Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Basal Cell Carcinoma
Via ACCESSWIRE
Earnings Scheduled For August 11, 2023
Via Benzinga
Biofrontera Inc. to Report Second Quarter Financial Results on August 11, 2023
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Biofrontera Inc. Announces Preliminary Second Quarter Revenues are Up 26% to 31%
Via ACCESSWIRE
Biofrontera Inc. Appoints Dr. Heikki Lanckriet to its Board of Directors
Via ACCESSWIRE
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Biofrontera Inc. Announces 1-for-20 Reverse Stock Split
Via ACCESSWIRE
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Virgin Galactic Are Trading Lower By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.